Dgmcmg
177 posts









I exercised caution on $BMNR for a while, anticipating the crypto winter that is now upon us… But with $ETH down substantially from the highs and the market exuberance flushing out, I believe the risk/reward has begun to shift into favor of the long term holder. Today I initiated my long position on $bmnr. Standing with Tom Lee (Fundstrat, not the drummer) on this one. Long $BMNR. @fundstrat






$UNH 4Q25 print necessitates a critical recalibration of our model, as the quarter’s noise—characterized by significant GAAP to adjusted deltas—masked a fundamentally robust narrative of operational execution and turnaround momentum heading into 2026. While the underwhelming Medicare 2027 Advance Notice presents a valuation headwind, UNH’s peerless scale and diversified ecosystem provide a structural buffer, allowing us to nudge our 2026e adjusted EPS to $17.77 on the back of superior UHC commercial performance and aggressive repricing strategies that more than offset persistent Medicaid margin compression. We anticipate a powerful 2027 pivot toward double digit growth as Optum’s run rate normalizes and portfolio wide pricing adjustments take hold, supporting our conviction in a multiyear margin recovery arc spanning 2026–2028. Consequently, we maintain a December 2026 price target of $389, derived from a 20.0x multiple on 2027e EPS—this premium valuation is justified by UNH’s clear line of sight to earnings acceleration and its historical ability to navigate regulatory volatility through sheer vertical integration. Despite near-term multiple pressure from CMS headwinds, the risk reward remains skewed to the upside as the "margin recovery story" transforms from a management thesis into realized bottom line expansion


@IndraStocks Carvana doesn’t sell more used cars than KMX.


















